Brain perfusion differences in Parkinsonian disorders

Movement Disorders

Volumn 26, Issue 14, 2011, Pages 2530-2537

  Kimura, Noriyuki ^a   Hanaki, Syojirou ^a   Masuda, Teruaki ^a   Hanaoka, Takuya ^a   Hazama, Yusuke ^a   Okazaki, Toshio ^a   Arakawa, Ryuki ^a   Kumamoto, Toshihide ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Brain perfusion SPECT; FineSRT; Parkinson variant of multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy; Statistical parametric mapping 8

Indexed keywords

ETHYLCYSTEINATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PARKINSONISM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; CEREBELLUM; CEREBROVASCULAR CIRCULATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 83555177350     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23915     Document Type: Article

References (24)

1. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94-98.
2. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
3. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia, and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia, and dementia. Arch Neurol 1964; 10: 333-359.
4. Kim YJ, Ichise M, Ballinger JR, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002; 17: 303-312.
5. Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur J Radiol 2004; 51: 223-233.
6. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010; 9: 149-158.
7. Waragai M, Yamada T, Matsuda H. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases. J Neurol Sci 2007; 260: 57-64.
8. Imon Y, Matsuda H, Ogawa M, et al. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999; 40: 1583-1589.
9. Matsui H, Udaka F, Miyoshi T, et al. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 2005; 11: 227-232.
10. Van Laere K, Santens P, Bosman T, et al. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004; 45: 933-942.
11. Okuda B, Tachibana H, Kawabata K, et al. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000; 14: 46-52.
12. Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 2006; 24: 538-544.
13. Kobayashi S, Tateno M, Utsumi K, et al. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT. J Neurol Sci 2008; 264: 27-33.
14. Kimura N, Kumamoto T, Masuda T, et al. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT. Clin Neurol Neurosurg 2009; 111: 829-834.
15. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992; 32: S125-S127.
16. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, et al, eds. Recent Developments in Parkinson's Disease. New York, NY: Macmillan; 1987: 153-163.
17. Matsuda H, Tsuji S, Shuke N, et al. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1993; 20: 391-401.
18. Lassen NA, Andersen AR, Friberg L, et al. The retention of [99mTc]-d, l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988; 8: S13-S22.
19. Friberg L, Andersen AR, Lassen NA, et al. Retention of 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 1994; 14: S19-S27.
20. Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990; 47: 747-752.
21. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12: 133-147.
22. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995; 118: 759-770.
23. Steele JC. Progressive supranuclear palsy. Brain 1972; 95: 693-704.
24. Behrman S, Carroll JD, Janota I, Matthews WB. Progressive supranuclear palsy. Clinico-pathological study of four cases. Brain 1969; 92: 663-678.